Papula-Nevinpat to partner with HealthSPA, the Finnish health startup association

4.4.2017

Papula-Nevinpat partners with HealthSPA, the Finnish health startup association, to raise awareness about the importance of IP rights in early-stage businesses where innovations and new technologies play a central role.

Papula-Nevinpat offers the members of HealthSPA free consulting on the best ways to support a new business with IP rights, such as patents, utility models, trademarks or design rights.

“Planning an IP strategy as early as possible is important to the success of a startup. Now our members can have free consulting with the experts from our new partner Papula-Nevinpat, who have wide experience in IP issues and technology relating to the health care and wellbeing industry, such as health care devices, wearables, electronics, software solutions, diagnostics and advanced biomaterials”, says Hanna Vartia, Director, HealthSPA ry.

“Health and wellbeing startups are part of a very exciting and important global theme, where a lot of effort is put to explore how our lives can be made healthier, safer and more comfortable. We are very proud to have the opportunity to support companies to succeed by offering our expertise in IP matters to the benefit of new health innovations and projects”, says Satu Lehesranta, European Patent Attorney, Papula-Nevinpat.

The Finnish health startup association, HealthSPA, is Finland’s most advanced health&wellbeing startup ecosystem booster. We are a non-profit organization supporting early-stage companies to grow by creating important contacts with industry, investors, media and industry experts. HealthSPA is also the founder and organizer of Upgraded Life Festival, Nordics biggest health startup event which will be held again on 25 – 26 April 2017.

News

Papula-Nevinpat again recognized as one of Finland’s leading practises in the 2019 Edition of WTR 1000

In the survey taking place for the ninth year, Papula-Nevinpat was ranked in the Silver Category in the prosecution and strategy sector.

Supplementary protection certificate extends the patent term by up to five and a half years – but who’s entitled?

The term of a pharmaceutical or plant production patent can be extended by a maximum of 5 years, up to 25 years altogether. Who is entitled and under which conditions? To find out read the blog by our experts Katja Feiring and Erja Partio.

Folke Johansson, Markku Simmelvuo and Marina Smirnova listed as WIPR Leaders 2019

Folke Johansson, who heads our firm’s patent department, and Markku Simmelvuo, our Managing Director, were both ranked in the patent category in Finland. In Russia, Marina Smirnova was ranked in both the patent and trademark categories.

Technology hype disconnects businesses from the product development reality

Our CDO Teemu Lang is blogging about AI hype. Artificial intelligence, or machine-learning algorithms, is a technology that is disruptive to our business as well, and enables new products and business models.